National Aluminium Company Limited

NSE: NATIONALUM · Metals & Mining · Lot size: 3750

National Aluminium Company Limited Open Interest & PCR Analysis

395.6Updated 5 Jun 2026, 03:30 pm IST
PCR
0.67
Bearish signal
Max Pain
420
Spot below by ₹24
Total CE OI
27.84M
Call writers
Total PE OI
18.64M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-06-05

Frequently Asked Questions

What is National Aluminium Company Limited PCR (Put-Call Ratio) today?
National Aluminium Company Limited's current PCR is 0.67. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. National Aluminium Company Limited's PCR of 0.67 indicates bearish sentiment.
What is National Aluminium Company Limited OI buildup type today?
National Aluminium Company Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for National Aluminium Company Limited?
National Aluminium Company Limited has total CE (call) OI of 27838125 contracts and total PE (put) OI of 18637500 contracts for the nearest expiry. The PCR is 0.67.
How is open interest analysis useful for National Aluminium Company Limited trading?
OI analysis for National Aluminium Company Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for National Aluminium Company Limited?
National Aluminium Company Limited's max pain is ₹420 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.